Trademark: 97542578
Word
RESMAXVY
Status
Pending
Status Code
686
Status Date
Tuesday, April 23, 2024
Serial Number
97542578
Mark Type
4
Filing Date
Wednesday, August 10, 2022
Published for Opposition
Tuesday, April 23, 2024

Trademark Owner History
Glaxo Group Limited - Owner At Publication

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Aug 13, 2022
New Application Entered
Aug 30, 2022
New Application Office Supplied Data Entered
May 26, 2023
Assigned To Examiner
May 30, 2023
Suspension Letter Written
May 30, 2023
Letter Of Suspension E-Mailed
May 30, 2023
Notification Of Letter Of Suspension E-Mailed
Jul 12, 2023
Teas Change Of Owner Address Received
Jul 12, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 12, 2023
Teas Change Of Correspondence Received
Sep 27, 2023
Teas Response To Suspension Inquiry Received
Jan 10, 2024
Suspension Checked - To Attorney For Action
Mar 15, 2024
Correspondence Received In Law Office
Mar 15, 2024
Teas/Email Correspondence Entered
Mar 18, 2024
Suspension Checked - To Attorney For Action
Mar 18, 2024
Approved For Pub - Principal Register
Apr 3, 2024
Notification Of Notice Of Publication E-Mailed
Apr 23, 2024
Published For Opposition
Apr 23, 2024
Official Gazette Publication Confirmation E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24